AL-S Pharma

AL-S Pharma AG is a special purpose company aimed at developing AP-101 to validate its concept. AL-S Pharma AG is a developer of treatments for Amyotrophic Lateral Sclerosis (ALS). AP-101 is a human monoclonal antibody targeting misfolded SOD1, used to combat ALS, a neurodegenerative disease with no known cure currently. The drug may offer therapeutic benefits for patients suffering from ALS.